• Skip to navigation (Press Enter).
  • Skip to main content (Press Enter).
Suche
  • Universitätsklinikum
  • Frauenklinik
  • Gesundheitstag 2011
  • Klinik für Gynäkologie und gynäkologische Onkologie
  • Klinik für Geburtshilfe und Perinatologie
  • Klinik für Endokrinologie und Reproduktionsmedizin
  • Kalender Fortbildungen
  • Forschung
  • Lehre
  • Sozial- oder Berufspraktikum
  • Galerie
  • uniklinik-plus
  • Notfallnummern
Grafik unten
Logo
  • Kontakt
  • So finden Sie uns
  • Klinikumseinrichtungen
  • Presse
Namensbildlinkesbildmittebildrechtesbild
Printer  Pdf
» » Gitsch » Lebenslauf
Google-Suchmaschine
Gesamte Uniklinikseite
Interne Suchmaschine
Aktuelle Uniklinikseite (frauenklinik)
Suche nach Stichworten
Begriffe, Krankheiten, Einrichtungen u.v.m., verknüpft mit dem zuständigen Bereich.
Personensuche
Nachname:
Vorname:
Akad. Titel:
Org.-Einheit:
phonetische Suche
Suche nach Einrichtungen:
Such-Bereich:
Bezeichnung:
phonetische Suche
Suche über die Einrichtungen
Im Menüpunkt "Übersicht" sind Einrichtungen unter verschiedenen Gesichtspunkten gruppiert: Kliniken, Abteilungen, Institute, Zentrale Einrichtungen und ähnliches.
Smart-Link
Seitenaufruf mit Smartlink--> Info hier!
smartlink-symbol

Univ. Prof. Dr. med. Dr. h. c. Gerald Gitsch

E-Mail: gerald.gitsch@uniklinik-freiburg.de
Tel. (0761) 270 - 30240
 
Beruflicher Werdegang
12.01.1960 geboren Wien
1966 - 1978 Piaristen-Grundschule und -Gymnasium Wien
1978 - 1984 Medizinstudium Universität Wien
1984 Promotion  
1984 - 1987 Ausbildung in Chirurgie, Kinderheilkunde und Innerer Medizin Krankenhaus Mödling
1987 - 1998   Universitäts-Frauenklinik Wien
23.01.1992 Facharzt für Gynäkologie und Geburtshilfe  
15.06.1992 Oberarzt  
16.05.1993 Habilitation  
1993 - 1994   Royal Hospital for Women, Sydney (Director: Prof. N. F. Hacker, MD)
23.01.1995 Facharzt für Zytologie  
1998 - 2000 Stellvertretender Leiter Universitäts-Frauenklinik, Freiburg
2000 - 2001 Leiter der Sektion Gynäkologische Gynäkologie Universitäts-Frauenklinik Wien
Ab 2001 Ärztlicher Direktor Universitäts-Frauenklinik Freiburg
Aktivitäten in wissenschaftlichen Gesellschaften
  • European Board and College of Obstetrics and Gynaecology (EBCOG), Board Member
  • International Gynecologic Cancer Society (IGCS), Board Member
  • European Society of Gynaecological Oncology (ESGO), Präsident
Mitgliedschaften in Editorial Boards
  • Anticancer Research
  • In Vivo
  • European Journal of Clinical & Medical Oncology
Visiting/Guest Professor
  • 1996: Baylor College of Medicine, Houston, Texas, USA
  • 1997: Royal Hospital for Women, University of New South Wales, Sydney, Australia
  • 1998: Tongji University, Wuhan, PR China
  • 1998: University of Beijing, PR China
  • 1999: University of Istanbul, Turkey
  • 2002: University of Beijing, PR China
Publikationen - MEDLINE-Zitierungen
  • 1. Philipp K, Skodler WD, Pateisky N, Gitsch G. Modification of uteroplacental circulation by solcoseryl. Zentralbl Gynakol (1987) 109(14):880-3.
  • 2. Gitsch G, Schatten C. Incidence and potential factors in the genesis of birth injury- induced calvicular fractures. Zentralbl Gynakol (1987) 109(14):909-12.
  • 3. Philipp K, Gitsch G, Skodler WD, Pateisky N. Attempt to diagnose a "small" placenta by HPL determination before the 18th week of pregnancy. Z Geburtshilfe Perinatol (1987) 191(2):64-7.
  • 4. Gitsch G, Wolf G. The possibility of stimulating the ureters with hexoprenaline follo wing radical abdominal surgery of cervix cancer. Zentralbl Gynakol (1988) 110(16):1030-3.
  • 5. Gitsch G. Case report of placenta praevia reflexa et increta. Geburtshilfe Frauenheilkd (1988) 48(8):603-5.
  • 6. Frischer T, Studnicka M, Hesse P, Gitsch G, Mutschlechner R, Neumann M. Air pollu tants and brochnial reactivity in primary school children 1. Wien Med Wochenschr Suppl (1989) 104:suppl 43-4.
  • 7. Gitsch G, Riss P, Janisch H. The Tompkins metroplasty in uterine abnormality, techni que and results. Gynakol Rundsch (1989) 29 Suppl 2:348-9.
  • 8. Gitsch G, Berger E, Tatra G. 30 years of vaginal hysterectomy at the 2nd University Gynecologic Clinic in Vienna, an analysis of over 6.000 operations. Gynakol Rundsch (1989) 29 Suppl 2:45-7.
  • 9. Neunteufel W, Gitsch G, Schieder K, Kolbl H, Breitenecker G. Carcinoma with low malignant potential (boderline tumor) of the ovary: immunomorphology and clinical aspects. Arch Gynecol Obstet (1989) 245(1-4):600-2.
  • 10. Gitsch E, Gitsch G. Schauta-Amreich expanded total vaginal excision in cervix cancer in relation to historical development. Gynakol Rundsch (1989) 29 Suppl 3:2-12.
  • 11. Neunteufel W, Gitsch G, Schieder K, Kolbl H, Breitenecker G. Ovarian tumors of low malignant potential (boderline tumors): immune morphology and current status. Anticancer Res (1989) 9(4):993-7.
  • 12. Gitsch G, Wirnsberger G, Reinthaller A, Neuteufel W, Tatra G, Breitenecker G. HPV detection in tissue and smear of cervix dysplasia by in situ hybridization. Gynakol Rundsch (1990) 30 Suppl 1:160-2.
  • 13. Breitenecker G, Gitsch G, Neunteufel W, Taberi U. Immunomorphologic findings in ovarian tumors. Gynakol Rundsch (1990) 30 Suppl 1:152-4.
  • 14. Breitenecker G, Dinges HP, Gitsch G. New nomenclature in gynecologic cytology. Gynakol Rundsch (1990) 30 Suppl 1:162-4.
  • 15. Rosen A, Klein M, Vavra N, Gitsch G, Karasegh S, Schrock A, Stiegelbauer M, Romig S. Pap IV in pregnancy--a retrospective multicenter study. Gynakol Rundsch (1990) 30 Suppl 1:190-3.
  • 16. Obwegeser R, Gitsch G, Muller-Tyl E, Riss P. Ambulatory care of vulvar diseases at the Vienna II. University Gynecologic Clinic: examinations, results and trends. Gynakol Rundsch (1990) 30 Suppl 1:224-6.
  • 17. Hanzal E, Kolbl H, Gitsch G, Bieglmayer C. Mucinous carcinoma-associated antigen (MCA) in ovarian cancer. Gynakol Rundsch (1990) 30 Suppl 1:68-70.
  • 18. Nowotny C, Miksche M, Kolbl H, Gitsch G, Hanzal E, Szepesi T. Therapy with biomodulators in ovarian cancer.
  • 19. Gitsch G, Riss P, Janisch H. Surgical correction of uterus abnormalities: experiences with the Tompkins method. Geburtshilfe Frauenheilkd (1990) 50(6):467-9.
  • 20. Gitsch G, Deutinger J, Bernaschek G. Prenatal diagnosis of a placental tumor using Doppler sonography. Geburtshilfe Frauenhilkd (1990) 50(12):986-8.
  • 21. Kainz C, Gitsch G, Reinthaller A, Kopp W, Tatra G, Breitenecker G. Cervix dysplasia and human papillomavirus infection in prostitutes. Gynakol Rundsch (1991) 31 Suppl 2:217-20.
  • 22. Kainz C, Gitsch G, Reinthaller A, Tatra G, Breitenecker G. Mild cervix dysplasia: does diagnostic biopsy have a "therapeutic" effect? Gynakol Rundsch (1991) 31 Suppl 2:223-5.
  • 23. Gitsch G, Kohlberger P, Hanzal E, Kolbl H, Breitenecker G. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas. Arch Gynecol Obstet (1991) 249(4):173-7.
  • 24. Gitsch G, Reinthaller A, Tatra G, Breitenecker G. Diagnosis of cervical intraepithelial neoplasia and human papillomavirus infection: punch biopsy versus cervical smear. Arch Gynecol Obstet (1991) 249(4):179-84.
  • 25. Gitsch G, Kohlberger P, Kolbl H, Krepler R, Breitenecker G. Immunohistochemical differentiation of granulosa cell tumors and ovarian cancers. Gynakol Rundsch (1991) 31 Suppl 2:370-2.
  • 26. Gitsch G, Berger E, Tatra G. Complications of vaginal hysterectomy under "difficult" circumstances. Arch Gynecol Obstet (1991) 249(4):209-12.
  • 27. Miholic J, Kolbl H, Hanzal E, Gitsch G, Schemper M, Moeschl P, Janisch H, Wolner E. The role of intestinal resection in primary surgery of ovarian carcinoma. Zentralbl Chir (1991) 116(7):465-70.
  • 28. Gitsch G, Berger E, Tatra G. Trends in thirty years of vaginal hysterectomy. Surg Gynecol Obstet (1991) 172(3):207-10.
  • 29. Rosen A, Klein M, Vavra N, Gitsch G, Karasegh S, Schrock A, Stiegelbauer M, Romig S. PAP IV in pregnancy--a retrospective multicenter study. Geburtshilfe Frauenheilkd (1991) 51(3):208-10.
  • 30. Koelbl H, Micksche M, Gitsch G, Hanzal E, Nowotny C. Treatment with biologic response modifiers in patients with ovarian cancer. Eur J Obstet Gynecol Reprod Biol (1991) 41(1):64-9.
  • 31. Gitsch G, Kainz C, Reinthaller A, Tatra G, Breitenecker G. Mild cervix dysplasia: does diagnostic biopsy have a "therapeutic" effect? Geburtshilfe Frauenheilkd (1991) 51(10):806-8.
  • 32. Gitsch G, Kainz C, Reinthaller A, Kopp W, Tatra G, Breitenecker G. Cervical neoplasia and human papilloma virus infection in prostitutes. Genitourin Med (1991) 67(6):478-80.
  • 33. Klein M, Rosen A, Vavra N, Gitsch G, Beck A. Conization in pregnancy and its signifi cance for the further course of pregnancy. Geburtshilfe Frauenheilkd (1991) 51(12):990-2.
  • 34. Lee A, Kainz C, Danihel L, Gitsch G, Dadak C, Breitenecker G. Lymph node metastasis in lobular breast cancer--an immunohistochemical study. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:107.
  • 35. Gitsch G, Reinthaller A, Kohlberger P, Breitenecker G. Immunohistochemical search for lymph node metastases in females with surgically treated cervix cancer. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:111.
  • 36. Joura E, Gitsch G, Kainz C, Frohlich B, Biegelmayr C, Kolbl H. Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:115.
  • 37. Kainz C, Gitsch G, Joura E, Breitenecker G. p53 protein in patients with Figo stage III cervix cancer. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:116.
  • 38. Gitsch G, Deutinger J, Reinthaller A, Breitenecker G, Bernaschek G. Effect of in flammatory stromal reaction on the value of rectal sonography in assessment of parametrial infiltration of cervix cancer. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:133.
  • 39. Joura E, Gitsch G, Kainz C, Berger E, Breitenecker G. Case report of primary irradiated melanoma of the cervix uteri. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:134.
  • 40. Kainz C, Gitsch G, Joura E, Hanzal E, Dadak C, Gruber W. Delivery in status post sectio 1976-1991. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:74-5.
  • 41. Gitsch G, Kainz C, Studnicka M, Reinthaller A, Tatra G, Breitenecker G. Oral con traceptives and human papillomavirus infection in cervical intraepithelial neoplasia. Arch Gynecol Obstet (1992) 252(1):25-30.
  • 42. Reinthaller A, Gitsch G, Kainz C, Berger E, Pohanka E, Kovarik J, Breitenecker G. Cervix dysplasia and HPV infections in females treated with immunosuppressive therapy. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:112-3.
  • 43. Klein M, Rosen A, Vavra N, Gitsch G, Schrock A, Beck A. PAP IV in pregnancy. Gynakol Geburtshilfliche Rundsch (1992) 32 Suppl 1:157.
  • 44. Gitsch G, Tabery U, Feigl W, Breitenecker G. The differential diagnosis of primary peritoneal papillary tumors. Arch Gynecol Obstet (1992) 251(3):139-44.
  • 45. Gitsch G, Kohlberger P, Steiner A, Neumeister B, Breitenecker G. Expression of cytokeratins in granulosa cell tumors and ovarian carcinomas. Arch Gynecol Obstet (1992) 251(4):193-7.
  • 46. Frischer T, Kuhr J, Gitsch G. Respiratory symptoms in children with low birth weight with or without perinatal respiratory insufficiency. Z Geburtshilfe Perinatol (1992) 196(1):11-4.
  • 47. Breitenecker G, Gitsch G. What's new in diagnosis and treatment of HPV-associated cervical lesions. Pathol Res Pract (1992) 188(1-2):242-7.
  • 48. Hanzal E, Gitsch G, Joura E, Dadak C, Breitenecker G. The value of intraoperative rapid biopsy study in diagnosis of breast cancer. Geburtshilfe Frauenheilkd (1992) 52(3):161-4.
  • 49. Gitsch G, Reinthaller A, Kohlberger P, Tatra G, Breitenecker G. Immunohistochemistry in pelvic nodes of patients with cervical cancer. Br J Obstet Gynaecol (1992) 99(3):265-6.
  • 50. Kainz C, Gitsch G, Reinthaller A, Kolbl H, Dadak C, Janisch H. Surgical treatment of invasive malignancies of the vulva using CO2 laser. Geburtshilfe Frauenheilkd (1992) 52(4):195-9.
  • 51. Joura E, Gitsch G, Kainz C, Breitenecker G. Primary Figo stage III melanoma of the uterine cervix. Geburtshilfe Frauenheilkd (1992) 52(6):367-8.
  • 52. Gitsch G, Deutinger J, Bernaschek G. The diagnostic value of rectal ultrasound in the assessment of parametrial infiltration of cervix cancer. Geburtshilfe Frauenheilkd (1992) 52(7):412-4.
  • 53. Gitsch G, Kainz C, Joura E, Frohlich B, Bieglmayr C, Tatra G. Squamous cell carcino ma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer. Anticancer Res (1992) 12(4):1247-9.
  • 54. Gitsch G, Kainz C, Kohlberger P, Schneider B, Danihel L, Koelbl H, Breitenecker G. Immunohistochemistry in stage FIGO III cervical cancer: prognostic value of tumor associated antigens and intermediate filaments. Anticancer Res (1992) 12(6B):2017-9.
  • 55. Gitsch G, Kainz C, Joura E, Breitenecker G. Mutant p53 product in patients with stage III cervical cancer. Anticancer Res (1992) 12(6B):2241-2.
  • 56. Hanzal E, Gitsch G, Kohlberger P, Dadak C, Miechowiecka N, Breitenecker G. Immu nohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival. Anticancer Res (1992) 12 (6B):2325-9.
  • 57. Gitsch G, Kainz C, Pohanka E, Reinthaller A, Kovarik J, Tatra G, Breitenecker G. Human papillomavirus infection of the uterine cervix in immune suppressed women after kidney transplantation. Geburtshilfe Frauenheilkd (1992) 52(12):764-6.
  • 58. Kainz C, Gitsch G, Lee A, Danihel L, Breitenecker G. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry. Anticancer Res (1993) 13(1):73-4.
  • 59. Kainz C, Prayer L, Gitsch G, Reinthaller A, Kolbl H. Diagnostic value of magnetic resonance study in after care of ovarian cancer. Gynakol Geburtshilfliche Rundsch (1993) 33 Suppl 1:219-20.
  • 60. Gitsch G, Kainz C, Breitenecker G. The incidence of positive cervix cytology 1980- 1989. Gynakol Geburtshilfliche Rundsch (1993) 33 Suppl 1:221.
  • 61. Reinthaller A, Kainz C, Gitsch G, Breitenecker G. Electrosurgical loop excision of premalignant changes in the uterine cervix with high frequency electric current. Gynakol Geburtshilfliche Rundsch (1993) 33 Suppl 1:222-3.
  • 62. Sam C, Kainz C, Kolbl H, Reinthaller A, Gitsch G, Dadak C, Janisch H. Surgical sterilization at the Vienna II. University Gynecologic Clinic 1984-1992. Gynakol Geburtshilfliche Rundsch (1993) 33 Suppl 1:314.
  • 63. Kainz C, Gitsch G, Stani J, Breitenecker G, Binder M, Schmidt JB. When applied to facial skin, does estrogen ointment have systemic effects? Arch Gynecol Obstet (1993) 253(2):71-4.
  • 64. Kainz C, Lee A, Gitsch G, Schneider B, Gruber W, Dadak C. 15 years vaginal delivery in post-cesarean status. Geburtshilfe Frauenheilkd (1993) 53(4):230-4.
  • 65. Gitsch G, Deutinger J, Reinthaller A, Breitenecker G, Bernaschek G. Cervical cancer: the diagnostic value of rectosonography for the judgement of parametrial invasion in regard of inflammatory stroma reaction. Br J Obstet Gynaecol (1993) 100(7):696-7.
  • 66. Kainz C, Gitsch G, Kohlberger P, Reinthaller A, Kolbl H, Breitenecker G. Human papillomavirus infections and carcinoembryonic antigen expression in cervix intra-epithelial neoplasia of intermediate grade. Pathologe (1993)14(5):264-6.
  • 67. Kainz C, Zeisler H, Kohlberger P, Gitsch G, Heinzl H, Breitenecker G, Reinthaller A. Prognostic value of cytokeratins and carcinoembryonic antigen expression in primary surgically treated cervical cancer. Anticancer Re (1994) 14(2B):667-71.
  • 68. Kainz C, Prayer L, Gitsch G, Stiglbauer R, Kramer J, Reinthaller A, Kolbl H. The diagnostic value of magnetic resonance imaging for the detection of tumor recurrence in patients with carcinoma of the ovaries. J Am Coll Surg (1994) 78(3):239-44.
  • 69. Kainz C, Gitsch G, Tempfer C, Heinzl H, Kolbl H, Breitenecker G, Reinthaller A. Vascular space invasion and inflammatory stromal reaction as prognostic factors in patients with surgically treated cervical cancer stage IB to IIB. Anticancer Res (1994) 14(5B):2245-8.
  • 70. Schmidt JB, Binder M, Macheiner W, Kainz C, Gitsch G, Bieglmayer C. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot study. Maturitas (1994) 20(1):25-30.
  • 71. Reinthaller A, Kainz C, Kohlberger P, Tempfer C, Gitsch G, Kolbl H, Breitenecker G. CD44 splice variants as prognostic factors in invasive cervix carcinoma. Gynakol Geburtshilfliche Rundsch (1995) 35(1):16-9.
  • 72. Kainz C, Tempfer C, Gitsch G, Heinzl H, Reinthaller A, Breitenecker G. Influence of age and human papillomavirus-infection on reliability of cervical cytopathology. Arch Gynecol Obstet (1995) 256(1):23-8.
  • 73. Gitsch G. Gynecologic oncology at the Royal Hospital for Women, Sydney. Report on a 10 month overseas stay. Gynakol Geburtshilfliche Rundsch (1995) 35(1):42-5.
  • 74. Gitsch G, van Eijkeren M, Hacker NF. Surgical therapy of vulvar cancer in pregnancy. Gynecol Oncol (1995) 56(2):312-5.
  • 75. Kainz C, Sliutz G, Mustafa G, Bieglmayr C, Koelbl H, Reinthaller A, Gitsch G. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer. Gynecol Oncol (1995) 56(3):402-5.
  • 76. Joura EA, Kainz C, Joura EM, Bohm R, Gruber W, Gitsch G. Comparison of surface tension with determination of the L/S ratio in amniotic fluid for prediction of fetal lung maturity. Z Geburtshilfe Neonatol (1995) 199(2):78-80.
  • 77. Gitsch G, Jensen DN, Hacker NF. A combined abdominoperineal approach for the resection of a large giant cell tumor of the sacrum. Gynecol Oncol (1995) 57(1):113-6.
  • 78. Gitsch G, Hanzal E, Jensen D, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol (1995) 85(4):504-8.
  • 79. Sliutz G, Tempfer C, Kainz C, Mustafa G, Gitsch G, Koelbl H, Biegelmayer C. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer. Anticancer Res (1995) 15(3):1127-9.
  • 80. Gitsch G, Friedlander ML, Wain GV, Hacker NF. Uterine papillary serous carcinoma. A clinical study. Cancer (1995) 75(9):2239-43.
  • 81. Kainz C, Kohlberger P, Gitsch G, Sliutz G, Breitenecker G, Reinthaller A. Mutant p53 in patients with invasive cervical cancer stages IB to IIB. Gynecol Oncol (1995) 57(2):212-4.
  • 82. Losch A, Kainz C, Gitsch G, Breitenecker G. Intravenous leiomyomatosis of the uterus. Gen Diagn Pathol (1995) 141(1):75-9.
  • 83. Kainz C, Gitsch G, Heinzl H, Breitenecker G. Incidence of cervical smears indicating dysplasia among Austrian women during the 1980s. Br J Obstet Gynaecol (1995) 102(7):541-4.
  • 84. Obermair A, Kurz C, Czerwenka K, Thoma M, Kaider A, Wagner T, Gitsch G, Sevelda P. Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int J Cancer (1995) 62(2):126-31.
  • 85. Sliutz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G, Kainz C. Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Lett (1995) 94(2):227-31.
  • 86. Kainz C, Kohlberger P, Tempfer C, Sliutz G, Gitsch G, Reinthaller A, Breitenecker G. Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer (1995) 31A(10):1706-9.
  • 87. Joura EA, Losch A, Kainz C, Sam C, Joura EM, Gitsch G, Dadak C, Breitenecker G. Infiltrating ductal carcinoma of the breast: extensive intraductal component has no impact on lymph node involvement and survival. Anticancer Res (1995) 15(5B):2285-6.
  • 88. Kohlberger P, Kainz C, Breitenecker G, Gitsch G, Sliutz G, Kolbl H, Tschachler E, Reinthaller A. Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma. Cancer (1995) 76(10):1786-9.
  • 89. Kohlberger P, Breitenecker G, Gitsch G, Sliutz G, Kolbl H, Tschachler E, Reinthaller A, Kainz C. Overexpression of p53 as prognosis factor in vulvar carcinoma. Gynakol Geburtshilfliche Rundsch (1996) 36(1):40-1.
  • 90. Loesch A, Kainz C, Gitsch G, Breitenecker G. Disseminated peritoneal leiomyomatosis. Wien Klin Wochenschr (1996) 108/5):153-6.
  • 91. Bancher-Todesca D, Seeber A, Tempfer C, Obermair A, Kucera E, Gitsch G, Kainz C. Behcet's disease of the uterine cervix--a case report. Wien Klin Wochenschr (1996) 108(21):689-91.
  • 92. Kohlberger P, Loesch A, Kolbl H, Breitenecker G, Kainz C, Gitsch G. Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer. Cancer Lett (1996) 98(2):151-5.
  • 93. Gitsch G. Therapy of vulvar carcinoma in the early stages. Geburtsh Frauenheilkd (1996) 56(2):63-9.
  • 94. Obermair A, Hanzal E, Schreiner-Frech I, Buxbaum P, Bancher-Todesca D, Thoma M, Kurz C, Vavra N, Gitsch G, Sevelda P. Influence of delayed diagnosis on established prognostic factors in endometrial cancer. Anticancer Res (1996) 16(2):947-9.
  • 95. Kohlberger P, Obermair A, Sliutz G, Heinzl H, Kolbl H, Breitenecker G, Gitsch G, Kainz C. Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. Am J Clin Pathol (1996) 105(6):705-10.
  • 96. Loesch A, Kohlberger P, Gitsch G, Kaider A, Breitenecker G, Kainz C. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Br J Cancer (1996) 73(12):1525-8.
  • 97. Kainz C, Tempfer C, Kohlberger P, Janisch S, Kolbl H, Gitsch G, Breitenecker G. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Int J Cancer (1996) 69(3):170-3.
  • 98. Tempfer C, Gitsch G, Hanzal E, Reinthaller A, Kolbl H, Kainz C. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma. Anticancer Res (1996) 16(4A):2029-31.
  • 99. Tempfer C, Gitsch G, Haeusler G, Reinthaller A, Koelbl H, Kainz C. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Cancer (1996) 78(2):273-7.
  • 100. Kohlberger P, Gitsch G, Loesch A, Tempfer C, Kaider A, Reinthaller A, Kainz C, Breitenecker G. p53 protein overexpression in early stage endometrial cancer. Gynecol Oncol (1996) 62(2):213-7.
  • 101. Obermair A, Kohlberger P, Bancher-Tedesca D, Tempfer C, Sliutz G, Leodolter S, Reinthaller A, Kainz C, Breitenecker G, Gitsch G. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol (1996) 63(2):204-9.
  • 102. Sliutz G, Schmidt W, Tempfer C, Speiser P, Gitsch G, Eder S, Schneeberger C, Kainz C, Zeillinger R. Detection of p53 point mutations in primary human vulva cancer by PCR and temperature gradient gel electrophoresis. Gynecol Oncol (1997) 64(1):93-8.
  • 103. Speiser P, Mayerhofer K, Kucera E, Roch G, Mittelbock M, Gitsch G, Zeillinger R. pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parameters. Anticancer Res (1997) 17(1B):679-83.
  • 104. Joura EA, Zeisler H, Bancher-Todesca D, Sator MO, Schneider B, Gitsch G. Short-term effects of topical testosterone in vulvar lichen sclerosus. Obstet Gynecol (1997) 89(2):297-9.
  • 105. Kohlberger P, Kieback DG, Breitenecker F, Loesch A, Gitsch G, Kainz C, Breitenecker G. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring. Gynecol Oncol (1997) 64(3):404-10.
  • 106. Bancher-Todesca D, Obermair A, Bilgi S, Kohlberger P, Kainz C, Breitenecker G, Leodolter S, Gitsch G. Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol (1997) 64(3):496-500.
  • 107. Speiser P, Wanner C, Tempfer C, Mittelbock M, Hanzal E, Bancher-Todesca D, Gitsch G, Reinthaller A, Kainz C. CD44 in an independent prognostic factor in early-stage cervical cancer. Int J Cancer (1997) 74(2):185-8.
  • 108. Zeisler H, Joura EA, Bancher-Todesca D, Hanzal E, Gitsch G. Prophylactic cerclage in pregnancy. Effect in women with a history of conization. J Reprod Med (1997) 42(7):390-2.
  • 109. Kohlberger P, Kieback DG, Bancher D, Stickeler E, Heinzl H, Gitsch G, Breitenecker G, Kainz C. Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium. Gynecol Oncol (1997) 66(2):227-32.
  • 110. Obermair A, Bancher-Todesca D, Bilgi S, Kaider A, Kohlberger P, Mullauer-Ertl S, Leodolter S, Gitsch G. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 89(16):1212-7.
  • 111. Kohlberger P, Kieback DG, Mian C, Wiener H, Kainz C, Gitsch G, Breitenecker G. Numerical chromosomal aberrations in borderline, benigne, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67. J Soc Gynecol Investig (1997) 4(5):262-4.
  • 112. Kohlberger P, Kirnbauer R, Bancher D, Gitsch G, Reinthaller A, Leodolter S, Tschach ler E, Kainz C, Breitenecker G. Absence of p53 protein overexpression in precancerous lesions of the vulva. Cancer (1998) 82(2):323-7.
  • 113. Haeusler G, Tempfer C, Gitsch G, Hanzal E. Omental evisceration after laparoscopic treatment of a tubal pregnancy. A case report and review of the literature. Gynecol Obstet Invest (1998) 45(1):66-7.
  • 114. Bancher-Todesca D, Gitsch G. Diagnosis an therapy of cervical intraepithelial dysplasia in Austria: a survey. Wien Klin Wochenschr (1997) 109(22):878-83.
  • 115. Obermair A, Wanner C, Bilgi S, Speiser P, Reisenberger K, Kaider A, Kainz C, Leodol ter S, Breitenecker G, Gitsch G. The infuence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen. Cancer (1998) 82(4):689-96.
  • 116. Obermair A, Wanner C, Bilgi S, Speiser P, Kaider A, Reinthaller A, Leodolter S, Gitsch G. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol (1998) 178(2):314-9.
  • 117. Hefler L, Tempfer C, Heinzl H, Haeusler G, Steindl P, Schneeberger C, Gitsch G, Kainz C. M3/M21 serum levels in women with adnexal masses and inflammatory diseases. Int J Cancer (1998) 79(4):434-8.
  • 118. Obermair A, Andisurya A, Kaider A, Sevelda P, Kolbl H, Gitsch G. The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer (1998) 83(4):726-31.
  • 119. Tempfer C, Obermair A, Hefler L, Haeusler G, Gitsch G, Kainz C. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol (1998) 92(3):360-3.
  • 120. Bancher-Todesca D, Gitsch G, Williams KE, Kohlberger P, Neunteufel W, Obermair H, Heinzl G, Breitenecker G, Hacker NF. p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma. Gynecol Oncol (1998) 71(1):59-63.
  • 121. Tempfer C, Hefler L, Heinzl H, Loesch A, Gitsch G, Rumpold H, Kainz C. CYFRA 21- 1 serum levels in women with adnexal masses and inflammatory diseases. Br J Cancer (1998) 78(8):1108-12.
  • 122. Kohlberger P, Joura EA, Bancher D, Gitsch G, Breitenecker G, Kieback DG. Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study. J Soc Gynecol Investig (1998) 5(6):331-3.
  • 123. Bancher-Todesca D, Rosen A, Graf A, Wasicky R, Hohlagschwandtner M, Rebhandl W, Heinl G, Breitenecker G, Gitsch G, Obermair A. Prognostic significance of tumor angiogenesis in primary fallopian tube cancer. Cancer Lett (1999) 141(1-2):179-86.
  • 124. Kohlberger P, Breitenecker F, Kaider A, Loesch A, Gitsch G, Breitenecker G, Kieback DG. Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: am comparison. Anticancer Res (1999) 19(3B):2189-93.
  • 125. Moser PL, Hefler L, Tempfer C, Neunteufel W, Kieback DG, Gitsch G. Immunohisto chemical detection of matrix metalloproteinases (MMP)1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer. Anticancer Res (1999) 19(3B):2365-7.
  • 126. Kohlberger P, Stani J, Gitsch G, Kieback DG, Breitenecker G. Comparative evaluation of seven cell collection devices for cervical smears. Acta Cytol (1999) 43(6):1023-6.
  • 127. Moser PL, Hefler L, Tempfer C, Neunteufel W, Kieback DG, Gitsch G. Immunohisto chemical detection of matrix metalloproteinases (MMP)1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II cervical cancer. Anticancer Res (1999) 19(5C):4391-3.
  • 128. Stimpfl M, Schmid BC, Obermair A, Tong D, Schiebel I, Gitsch G, Leodolter S, Zeillinger R. Comparison of flow cytometry and RT-PCR for detection of ovarian cancer cells in peripheral blood. Oncol Res (1999) 11(8):367-73.
  • 129. Hasenburg A, Grothey A, Jaspers V, Gitsch G, Spätling L. Breast size as risk factor for tumor size at diagnosis. Anticancer Res (2000) 20(3B):2041-4.
  • 130. Herouy Y, Aizpurua J, Stetter C, Dichmann S, Idzko M, Hofmann C, Gitsch G, Vanscheidt W, Schopf E, Norgauer J. The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD 87) in lipodermatosclerosis. J Cutan Pathol (2001) 28(6):291-7.
  • 131. Kohlberger P, Gantert M, Volk-Orlowska T, Kieback DG, Gitsch G. Immunohisto- chemical detection of lymph node metastases in node negative breast cancer patients. Anticancer Res (2001) 21(1B)697-9.
  • 132. Van der Velden J, Gitsch G, Wain GV, Friedlander ML, Hacker NF. Tamoxifen in patients with recurrent epithelial ovarian cancer. Int J Gynecol Cancer (1995) 5(4):301-305
  • 133: Girardi F, Pickel H, Joura EA, Breitenecker G, Gitsch G, Graf AH, Neunteufel W. Guidelines for diagnosis and therapy of intraepithelial neoplasia and early invasive carcinoma of the female lower genital system (cervix uteri, vagina, vulva) established by the AGK (Colposcopy Work Group in the OGGG. Austrian Society of Gynecology and Obstetrics) Gynakol Geburtshilfliche Rundsch (2001) 41(3):197-200.
  • 134: Hefler LA, Ludwig E, Lampe D, Zeillinger R, Leodolter S, Gitsch G, Koelbl H, Tempfer CB. Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol (2002) 86(2):134-7.
  • 135: Horch RE, Gitsch G, Schultze-Seemann W. Bilateral pedicled myocutaneous vertical rectus abdominus muscle flaps to close vesicovaginal and pouch-vaginal fistulas with simultaneous vaginal and perineal reconstruction in irradiated pelvic wounds. Urology (2002) 60(3):502-7.
  • 136: Földi M, Randelzhofer B, Gitsch G. Symptomatic skeletal muscle metastasis and elephantiastic lymphedema in a patient with recurrent ovarian carcinoma. Gynecol Oncol (2003) 90(2):471-3.
  • 137: Denschlag D, Watermann D, Hörig K, Kissel C, Tempfer C, Gitsch G. Topotecan as a continuous infusion over 14 days in recurrent ovarian cancer patients. Anticancer Res (2004) 24(2C):1267-9.
  • 138: Gabriel B, Mildenberger S, Weisser CW, Metzger E, Gitsch G, Schüle R, Müller JM. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res (2004) 24(2B):921-7.
  • 139: Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, Gitsch G, Leodolter S, Tempfer CB. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol Oncol (2004) 93(3):686-90.
  • 140: Weissenberger C, Jonassen S, Beranek-Chiu J, Neumann M, Müller D, Bartelt S, Schulz S, Mönting JS, Henne K, Gitsch G, Witucki G. Breast cancer: patient information needs reflected in English and German web sites. Br J Cancer (2004) 91(8):1482-7.
  • 141: Denschlag D, Gabriel B, Mueller-Lantzsch C, Tempfer C, Henne K, Gitsch G, Hasenburg A. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Gynecol Oncol (2005) 96(3):658-64.
  • 142: Denschlag D, Kontny U, Tempfer C, Orlowska-Volk M, Niemeyer C, Gitsch G. Low-grade myxofibrosarcoma of the vulva in a 15-year-old adolescent: a case report. Int J Surg Pathol (2005) 13(1):117-9.
  • 143: Gabriel B, Denschlag D, Göbel H, Fittkow C, Werner M, Gitsch G, Watermann D. Uterosacral ligament in postmenopausal women with or without pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2005) 16(6):475-9.
  • 144: Tempfer CB, Riener EK, Keck C, Grimm C, Heinze G, Huber JC, Gitsch G, Hefler LA. Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women. Menopause (2005) 12(3):325-30.
  • 145: Watermann DO, Földi M, Hanjalic-Beck A, Hasenburg A, Lüghausen A, Prömpeler H, Gitsch G, Stickeler E. Three-dimensional ultrasound for the assessment of breast lesions. Ultrasound Obstet Gynecol (2005) 25(6):592-8.
  • 146: Watermann DO, Gabriel B, Jäger M, Orlowska-Volk M, Hasenburg A, zur Hausen A, Gitsch G, Stickeler E. Specific induction of pp125 focal adhesion kinase in human breast cancer. Br J Cancer (2005) 93(6):694-8.
  • 147: Gabriel B, Watermann D, Hancke K, Gitsch G, Werner M, Tempfer C, Hausen A. Increased expression of matrix metalloproteinase 2 in uterosacral ligaments is associated with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2006) 17(5):478-82.
  • 148: Beckmann MW, Gitsch G, Emons G, Berg D, Kaufmann M. Qualification and education in gynecological oncology. Zentralbl Gynakol (2006) 128(1):1-4.
  • 149: Gabriel B, zur Hausen A, Stickeler E, Dietz C, Gitsch G, Fischer DC, Bouda J, Tempfer C, Hasenburg A. Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clin Cancer Res (2006) 12(8):2476-83.
  • 150: Földi M, Stickeler E, Bau L, Kretz O, Watermann D, Gitsch G, Kayser G, Zur Hausen A, Coy JF. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer. Oncol Rep (2007) 17(4):841-5.
  • 151: Sagr ER, Denschlag D, Kerim-Dikeni A, Stanimir G, Gitsch G, Gilbert L. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma. Anticancer Res (2007) 27(2):1213-7.
  • 152: Lassmann S, Shen Y, Jütting U, Wiehle P, Walch A, Gitsch G, Hasenburg A, Werner M. Predictive value of Aurora-A/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy. Clin Cancer Res (2007) 13(14):4083-91.
  • 153: Vergote I, van der Zee AG, Kesic V, Sert B, Robova H, Rob L, Reed N, Luesley DM, Leblanc E, Hagen B, Gitsch G, du Bois A, di Vagno G, Colombo N, Beller U, Ayhan A, Jacobs I. ESGO statement on cervical cancer vaccination. Int J Gynecol Cancer (2007) 17(6):1183-5.
  • 154: Klar M, Jochmann A, Foeldi M, Stumpf M, Gitsch G, Stickeler E, Watermann D. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat (2008) 112(3):523-31.
  • 155: Lassmann S, Shen Y, Jütting U, Whiele P, Walch A, Gitsch G, Hasenburg A, Werner M. Aurora-a is a predictive marker for stage III epithelial ovarian cancers. Verh Dtsch Ges Pathol (2007) 91:225-32.
  • 156: Mayer S, zur Hausen A, Watermann DO, Stamm S, Jäger M, Gitsch G, Stickeler E. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients. J Cancer Res Clin Oncol (2008) 134(11):1229-35.
unterer Abschluss
Impressum